ANIP: Summary for ANI Pharmaceuticals, Inc. - Yahoo Finance

Singapore Markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
45.99+0.45 (+0.99%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous close45.54
Bid43.50 x 1000
Ask0.00 x
Day's range45.56 - 46.14
52-week range30.60 - 70.92
Avg. volume157,506
Market cap533.01M
PE ratio (TTM)135.26
Earnings dateN/A
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Zacks13 days ago

    Moving Average Crossover Alert: ANI Pharmaceuticals (ANIP)

    ANI Pharmaceuticals, Inc. (ANIP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

  • ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017
    Capital Cube18 days ago

    ANI Pharmaceuticals, Inc. :ANIP-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017

    Categories: Yahoo Finance Get free summary analysis ANI Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of ANI Pharmaceuticals, Inc. – Jazz Pharmaceuticals Plc, Mylan N.V., Teva Pharmaceutical Industries Limited Sponsored ADR, Lannett Company, Inc. and Pfizer Inc. (JAZZ-US, MYL-US, TEVA-US, LCI-US and PFE-US) that ... Read more (Read more...)

  • Associated Press24 days ago

    ANI reports 4Q loss

    On a per-share basis, the Baudette, Minnesota-based company said it had a loss of 9 cents. Earnings, adjusted for one-time gains and costs, came to 90 cents per share. The drugmaker posted revenue of $38.2 ...